🔗 Share this article

Chancellor Rachel Reeves has stated she is preparing "specific action to deal with household expense pressures" in the forthcoming Budget.

During an interview with media outlets, she noted that curbing price rises is a collective duty of both the administration and the central bank.

The UK's inflation rate is forecast to be the most elevated among the G7 industrialized countries this year and the following year.

Possible Energy Bill Measures

Sources suggest the administration could intervene to bring down energy bills, for instance by reducing the present 5% rate of value-added tax applied on energy supplies.

An additional possibility is to cut some of the regulatory levies presently included in bills.

Budgetary Limitations and Analyst Expectations

The administration will obtain the next assessment from the independent fiscal watchdog, the OBR, on the start of the week, which will clarify how much space there is for these actions.

The expectation from the majority of economists is that Reeves will have to announce tax increases or budget cuts in order to fulfill her voluntary fiscal targets.

Earlier on Thursday, estimates indicated there was a £22bn deficit for the chancellor to fill, which is at the more modest range of forecasts.

"It is a shared task between the Bank of England and the government to further reduce some of the drivers of inflation," Reeves told the BBC in the US capital, at the yearly gatherings of the IMF and World Bank.

Tax Commitments and Global Issues

While much of the focus has been on likely tax increases, the Treasury chief said the most recent data from the OBR had not changed her vow to election pledges not to raise tax levels on earnings tax, VAT or social security contributions.

She attributed an "uncertain world" with increasing geopolitical and commercial issues for the fiscal tax moves, likely to be focused on those "wealthiest."

International Trade Tensions

Commenting on worries about the United Kingdom's trade ties with the Asian nation she said: "The UK's security interests always are paramount."

Last week's statement by Chinese authorities to tighten trade restrictions on critical minerals and other resources that are crucial for advanced tech production led US President the US President to threaten an additional 100% tariff on goods from China, raising the risk of an all-out trade war between the two economic giants.

The US Treasury Secretary called the Chinese action "economic coercion" and "a international production power grab."

Asked about considering the US offer to join its battle with the Asian nation, Reeves said she was "very concerned" by China's measures and encouraged the Beijing authorities "to avoid restrictions and limit trade."

She said the move was "bad for the international commerce and creates further challenges."

"I believe there are sectors where we need to confront China, but there are also valuable chances to sell into China's economy, including financial services and other sectors of the economic system. We've got to achieve that balance appropriate."

The Treasury chief also confirmed she was cooperating with G7 counterparts "regarding our own essential resources plan, so that we are more independent."

Health Service Medicine Pricing and Funding

The Chancellor also acknowledged that the cost the National Health Service spends on pharmaceuticals could increase as a consequence of current negotiations with the Trump administration and its drugs companies, in return for lower tariffs and investment.

A number of the biggest global drug companies have said lately that they are either halting or scrapping operations in the UK, with some attributing the insufficient payments they are getting.

Last month, the government science advisor said the cost the health service spends on drugs would have to go up to prevent businesses and drug research funding leaving the United Kingdom.

Reeves stated to the BBC: "It has been observed due to the pricing regime, that drug testing, new drugs have not been available in the UK in the extent that they are in other EU nations."

"Our aim is to ensure that individuals receiving treatment from the NHS are can obtain the finest essential drugs in the world. And so we are examining these issues, and... seeking to attract additional investment into Britain."